Inhibitors of Human Histone Deacetylase: Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates
Authors:
- 17 January 2002
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (4) , 753-757
Abstract
Inhibitors of histone deacetylase (HDAC) have been shown to induce terminal differentiation of human tumor cell lines and to have antitumor effects in vivo. We have prepared analogues of suberoylanilide hydroxamic acid (SAHA) and trichostatin A and have evaluated them in a human HDAC enzyme inhibition assay, a p21waf1 (p21) promoter assay, and in monolayer growth inhibition assays. One compound, 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-benzamide, was found to affect the growth of a panel of eight human tumor cell lines differentially.Keywords
This publication has 9 references indexed in Scilit:
- Histone deacetylases, transcriptional control, and cancerJournal of Cellular Physiology, 2000
- When the band begins to play: Histone acetylation caught in the crossfire of gene controlMolecular Carcinogenesis, 2000
- Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative EffectsJournal of Biological Chemistry, 1999
- Inhibitors of Histone Deacetylase Suppress the Growth of MCF-7 Breast Cancer CellsArchiv der Pharmazie, 1999
- Histone deacetylase inhibitors: novel anticancer agentsExpert Opinion on Investigational Drugs, 1999
- The bromodomain: a chromatin-targeting module?Nature Structural & Molecular Biology, 1999
- Histone acetylation and cancerCurrent Opinion in Genetics & Development, 1999
- Histone acetylases and deacetylases in cell proliferationCurrent Opinion in Genetics & Development, 1999
- The Synthesis of N-Hydroxy-N'-phenyloctanediamide and Its Inhibitory Effect on Proliferation of AXC Rat Prostate Cancer CellsJournal of Medicinal Chemistry, 1995